May Life Cycle Management safeguard Innovation in the Pharmaceutical Industry?
Type
journal article
Date Issued
2018
Author(s)
Abstract (De)
The pharmaceutical industry invests enormous amounts of resources ( > >€1 billion and >10 years) in the development of new products. External factors such as intensifying foreign competition and greater regulatory demands can negatively affect the profit margin, whereas the R&D productivity diminishes. To stay competitive and to maintain high R&D capabilities for developing new medicinal products, companies must make smart investment decisions to maximize their return on investment. Consequently, the entire lifecycle of a medicinal product must be effectively managed to ensure a sustained development through commercialization. This review critically assesses the current situation and the associated management strategies throughout the lifecycle of a medicinal product.
Language
English
Refereed
Yes
Publisher
Drug Discovery Today
Subject(s)
Division(s)
Eprints ID
255587